Medication info
SamAh Acyclovir Tablets

SamAh Acyclovir Tablets

Prescription medicationTablet
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
SamAh Pharmaceutical Co., Ltd.
Appearance
The tablet is round, bluish-white in color and may have blue specks.
Packaging
30 tablets, 500 tablets (bottle)
Approval status
Active

MFDS item code 199800889 · Notified 1998.09.29 · Insurance code 645700660

Summary

Main use
Treatment of herpes zoster; treatment and prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe primary infection. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Administration as soon as possible after infection is recommended. In recurrent cases, it is preferable to start treatment when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its effectiveness. 3) To assess the natural course of the disease, long-term treatment should be periodically discontinued every 6 ~ 12 months. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunodeficiency or gastrointestinal malabsorption. 3) Administration as soon as possible after infection is recommended; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Since patients with renal impairment are more likely to experience adverse reactions involving the central nervous system, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/min), it is preferable to administer 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL/min, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL/min, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — 2 years and older: Same as for adults. 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — Under 2 years: Administer 1/2 the adult dose. 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — There are currently no conclusive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment is more effective the earlier it is started after the chickenpox rash appears, and should be given within 24 hours of rash onset whenever possible.

Ingredients

Manufacturer
SamAh Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of herpes zoster; treatment and prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older

  • Primary genital herpes
  • recurrent genital herpes
  • herpes simplex virus infections of the skin and mucosal tissues
  • herpes zoster virus infections
  • acute pain
  • and chickenpox.
View approved original text

This medication is used to treat and prevent infections caused by the herpes simplex virus, including primary and recurrent genital herpes, as well as herpes zoster virus infections. It is particularly effective in alleviating acute pain associated with herpes zoster. However, its efficacy against postherpetic neuralgia has not been clearly established. This drug is also used for the treatment of chickenpox in children aged over 2 years. Overall, this medication helps treat various viral infectious diseases and contributes to symptom relief.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe primary infection. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Administration as soon as possible after infection is recommended. In recurrent cases, it is preferable to start treatment when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its effectiveness. 3) To assess the natural course of the disease, long-term treatment should be periodically discontinued every 6 ~ 12 months. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunodeficiency or gastrointestinal malabsorption. 3) Administration as soon as possible after infection is recommended; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Since patients with renal impairment are more likely to experience adverse reactions involving the central nervous system, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/min), it is preferable to administer 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL/min, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL/min, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — 2 years and older: Same as for adults. 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — Under 2 years: Administer 1/2 the adult dose. 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — There are currently no conclusive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment is more effective the earlier it is started after the chickenpox rash appears, and should be given within 24 hours of rash onset whenever possible.

Precautions

This drug should not be used in patients with specific allergic reactions or genetic metabolic disorders such as lactose intolerance. Patients with kidney or liver dysfunction, children, and the elderly should exercise particular caution when using this medication. Rarely, serious side effects such as severe allergic reactions, skin rashes, mental confusion, or kidney function impairment may occur during treatment, and immediate consultation with a physician is necessary if unusual symptoms appear. To enhance therapeutic effectiveness, it is important to take this medication early in the course of the outbreak, and alternative therapies should be considered if symptoms do not improve or worsen. Adequate hydration is necessary during treatment to prevent dehydration and kidney damage. Caution is advised during activities requiring mental alertness, such as driving or operating machinery, as consciousness disturbances may occur. When taking this drug with other medications, the effects or side effects of this drug may change, so it is essential to inform the physician or pharmacist about any other medications currently being taken. Women who are pregnant or breastfeeding should carefully consider the potential effects on the fetus or infant when using this drug, and it is advisable to discontinue breastfeeding during the treatment period. In children and the elderly, dosage adjustment may be needed based on physical condition, with special caution required in cases of decreased kidney function. Overdosing this medication can lead to severe neurological symptoms or kidney damage, so the dosage should be strictly followed, and immediate medical consultation is required in the event of an overdose.

Side effects

  • Anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • dyspnea
  • chest tightness
  • phototoxic reaction
  • fixed drug eruptions
  • rash
  • fever
  • vesicles
Show 121 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration difficulties
  • aggressive behavior
  • depersonalization
  • agitation
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • convulsions
  • drowsiness
  • tremors
  • excitement
  • forgetfulness
  • insomnia
  • anxiety
  • talking to oneself
  • paresthesia
  • ataxia
  • gait disturbance
  • involuntary movements
  • nystagmus
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytic vasculitis
  • lymphadenopathy
  • hemorrhage
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • elevated AST
  • elevated ALT
  • elevated LDH
  • elevated ALP
  • elevated total bilirubin
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • abdominal pain
  • epigastric pain
  • abdominal pain
  • nausea
  • vomiting
  • indigestion
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • generalized malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • hair loss
  • sweating
  • hyponatremia
  • hypoproteinemia
  • elevated total cholesterol
  • elevated triglycerides
  • elevated serum potassium
  • decreased serum albumin
  • agitation
  • coma
  • seizures
  • lethargy
  • confusion
  • hallucinations
  • excitement
  • epileptic seizures
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It should be kept in a cool and dry place at a temperature below 25 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

The tablet is round, bluish-white in color and may have blue specks.

Package unit

30 tablets, 500 tablets (bottle)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.